The inherited predisposition for prostate cancer implicates prostate cell and tissue repair (DNA double-strand break and mismatch repair genes) and regeneration (HOXB13 and putative MYC enhancer) in disease pathogenesis. This evidence concerns the gene HOXB13 and prostate carcinoma.